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ABSTRACT
The E3L gene is essential for pathogenesis in
vaccinia virus. The E3L gene product consists of
an N-terminal Za domain and a C-terminal double-
stranded RNA (dsRNA) binding domain; the left-
handed Z-DNA-binding activity of the Za domain
of E3L is required for viral pathogenicity in mice.
E3L is highly conserved among poxviruses, includ-
ing the smallpox virus, and it is likely that the
orthologous Za domains play similar roles. To better
understand the biological function of E3L proteins,
we have investigated the Z-DNA-binding behavior
of five representative Za domains from poxviruses.
Using surface plasmon resonance (SPR), we have
demonstrated that these viral Za domains bind
Z-DNA tightly. Ability of ZaE3L converting B-DNA to
Z-DNA was measured by circular dichroism (CD).
The extents to which these Zas can stabilize Z-DNA
vary considerably. Mutational studies demonstrate
that residues in the loop of the b-wing play an
important role in this stabilization. Notably the Za
domain of vaccinia E3L acquires ability to convert
B-DNA to Z-DNA by mutating amino acid residues in
this region. Differences in the host cells of the
various poxviruses may require different abilities
to stabilize Z-DNA; this may be reflected in the
observed differences in behavior in these Za
proteins.
INTRODUCTION
Poxviruses are the largest, most complex, double-stranded
DNA viruses that have been observed to replicate in the
cytoplasm of infected cells (1,2). Each poxvirus exhibits
a diﬀerent host range; some are extremely species speciﬁc,
for example, swinepox virus, while others exhibit a broad
host range (3,4). Vaccinia virus is the best-characterized
member of this large family, due to its long established
role in vaccination against smallpox as well as its
importance as a gene transfer vehicles (1).
The E3L protein of vaccinia virus is composed of two
distinct domains associated with two diﬀerent nucleic
acid-binding properties. The N-terminal domain (Za)
binds tightly and speciﬁcally to left-handed Z-DNA
(5–8), while the C-terminal domain comprises a well-
characterized double-stranded RNA (dsRNA) binding
domain (9–12). The dsRNA-binding domain allows the
virus to overcome host defense systems mediated by the
dsRNA activated protein kinase PKR (9). Vaccinia virus
lacking the dsRNA-binding domain of E3L has an
increased sensitivity to IFN and restricted host range
(13). The Z-DNA-binding domain is a member of the Za
family of Z-DNA-binding proteins, whose other members
include the vertebrate dsRNA editing enzyme ADAR1
and the mammalian Z-DNA-binding protein ZBP1
(previously known as DLM-1).
The molecular structures of several Za domains have
been determined. Za:Z-DNA co-crystal structures have
been solved for the Za domains of human ADAR1 (14),
mouse ZBP1 (15) and yaba-like disease virus E3L (16).
In each case, the protein adopts a helix-turn-helix with
b-sheet (winged helix-turn-helix) fold, with the left-handed
DNA backbone grasped between the recognition helix
and the b-sheet by numerous hydrogen bonds. Both the
precise shape of the fold and the interaction with DNA
are extremely similar among these proteins. The DNA-
contacting residues are highly conserved, both between
species within a given protein and between diﬀerent
members of the Za family (15,16), however, diﬀerent
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The solution structure of free vaccinia virus ZaE3L shows
the same overall fold and supports the concept that E3L
proteins share their Z-DNA-binding mode (17). There is
one provocative diﬀerence between the diﬀerent Za
structures: although the contacts between the b-sheet
and the DNA are nearly the same, the shape and position
of the b-sheet is variable, diﬀering in each or the
determined structures (16,17).
In previous studies, the Z-DNA-binding domain of
E3L protein from vaccinia virus (vZaE3L) was shown
to play a key role in viral pathogenesis in mice (18,19).
Furthermore, it was shown that the ability to bind
Z-DNA is the essential characteristic required for the
biological activity of this domain; vZaE3L can be replaced
with the Za domain of either ADAR1 or ZBP1 with no
loss of viral pathogenicity. Mutations that decrease or
abolish Z-DNA-binding activity proportionately decrease
or abolish pathogenicity (19). It has been demonstrated
that the Z-DNA-binding activity of vZaE3L is responsible
for the anti-apoptotic activity of vaccinia E3L when
expressed in cultured cells and can activate expression of
a battery of genes (20). Therefore, it is of interest
to characterize the binding activity of viral Za domains
in order to better understand poxvirus infection.
In this study, we have expressed the ZaE3L domains
from a representative group of ﬁve poxviruses: vaccinia
virus (vZaE3L), swinepox virus (spZaE3L), yaba-like
disease virus (yabZaE3L), orf virus (orfZaE3L) and lumpy
skin disease virus (lsZaE3L) (Figure 1).We show that
these proteins bind strongly to Z-DNA and alter the
equilibrium between B-DNA and Z-DNA. In addition,
we have modiﬁed the b-sheets of several of these proteins
using site-directed mutagenesis. These modiﬁed proteins
display altered Z-DNA-binding activity, showing that
changes in this region can modulate the interaction
between protein and Z-DNA. These modulations are
similar in magnitude to diﬀerences between the E3Ls
of several poxviruses. It remains to be determined whether
such changes in binding activity would alter the biology
of the virus.
MATERIALS AND METHODS
Proteinexpression andpurification
The sequences encoding viral Za domains were either
ampliﬁed from viral genomic DNAs (orfZaE3L and
vZaE3L) by PCR or assembled from synthesized oligonu-
cleotides (lsZaE3L, spZaE3L and yabZaE3L) and cloned
into the expression vector pET28a (Novagen), to be
expressed as N-terminal-(His)6-tagged fusion proteins.
Expression clones were conﬁrmed by restriction enzyme
analysis and DNA sequencing. Resulting vectors were
transformed into Escherichia coli strain BL21(DE3).
Expression and puriﬁcation of viral Zas were carried
out essentially as described elsewhere (16,21). Brieﬂy,
cells were grown at 378C in LB medium supplemented
with 30 mg/ml kanamycin until they reached a ﬁnal
concentration of OD600=0.5 0.7, at which time IPTG
was added to 0.5mM. Protein was expressed for 4h at
378C with the exception of yabZaE3L, which was induced
at 188C (16). Cells were harvested by centrifugation
Figure 1. Sequence alignment of viral Za domains and related Za domains. It is shown underneath the secondary structure diagram, as revealed in
the co-crystal structures of hZaADAR1,m Z aZBP1 and yabZaE3L (14–16). Residues interacting with Z-DNA (blue triangles) and residues important for
the protein fold (pink dots) are indicated. Yellow bars indicate residues that are important for the protein fold or Z-DNA recognition. Human
ZbADAR1, which lacks the key tyrosine in helix a-3, does not bind to Z-DNA. In contrast, the Zb domain from zebraﬁsh ADAR1, which possesses
this tyrosine, is capable of inducing the B–Z transition (8). The GenBank accession numbers for the various sequences are as follows: double-
stranded RNA adenosine deaminase 1 (Homo sapiens): AAB06697 [GenBank]; Z-DNA-binding protein 1 (Mus musculus): NP_067369 [GenBank]; the
E3L proteins: (vaccinia virus): AAA02759 [GenBank]; (orf virus): AAC08018 [GenBank]; (lumpy skin disease virus): AAK84995 [GenBank];
(swinepox): NP_570192 [GenBank]; (yaba-like disease virus): NP_073419 [GenBank]. Amino acids residues located at P-2 and P-1 positions of the
b-wing regions in viral Zas are in bold.
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chelating column (AP biotech), followed by removal of the
N-terminal (His)6-tag with thrombin (Boehringer
Mannheim). Za was further puriﬁed by ion exchange
chromatography (GE), and dialyzed against 5mM
HEPES, pH 7.5, 10mM NaCl, except yabZaE3L and
its mutants, which have limited solubility in low salt,
forwhich100mMNaClwasused(16).Thepuriﬁedprotein
was adjusted to >2mM ﬁnal concentration, as determined
by UV absorbance at 280nm, using extinction coeﬃcients
deduced from amino acid sequence. The puriﬁed proteins
were stored frozen at  708C until use.
Surface plasmonresonance analysis
The binding aﬃnities of viral Zas for Z-DNA were
determined by surface plasmon resonance (SPR) using a
BIAcore 2000 as described previously (5). Brieﬂy, ca. 300
response units (RU) of biotinylated poly (dG–dC)
stabilized in the Z conformation (22) were immobilized
on a SA chip (Biacore). Protein solutions at concentrations
between 75nM and 2000nM were passed over the chip
surface at 20ml/min. All experiments were carried out at
258C in HBS buﬀer (10mM HEPES, pH 7.4, 150mM
NaCl, 0.01mM EDTA). Regeneration was performed with
a pulse of 0.05% SDS. The association and dissociation
times were 180 and 200s, respectively. For analysis,
binding curves were ﬁtted using BIA evaluation 3.0 and
the 1:1 binding drifting baseline model.
Circulardichroism (CD)
Poly (dG–dC) (AP biotech) was rehydrated with
10mM Tris–Cl, pH 7.4, 100mM NaCl prior to use. The
conversion of poly (dG–dC) from the B to the
Z conformation was monitored by circular dichroism
(CD). CD spectra were taken at 258C using a Jasco J-810
CD spectrophotometer. Measurements were carried out
on 150mg/ml (225mM base pair) DNA in CD buﬀer
(10mM HEPES, pH 7.4, 10mM NaCl and 0.1mM
EDTA) in a 2mm quartz cell for all proteins except
yabZaE3L and its mutants, which included 100mM NaCl.
To the DNA, 90mM (ﬁnal concentration) protein
was added. The maximum volume of protein added to
the sample did not exceed 5% of the total. Wavelength
spectra were recorded at 1nm interval averaged over 3s.
For kinetic measurements, CD signal changes at 255nm
were recorded at 1s intervals for 1h.
Mutagenesis ofviral Zas
Mutant proteins were constructed using the QuikChange
site-directed mutagenesis kit (Stratagene), according to the
instructions provided by the supplier. After PCR and
cloning, the sequence of each construct was veriﬁed.
RESULTS AND DISCUSSION
We chose ﬁve representative viral Zas from several
subfamilies of poxvirus for careful examination.
The amino acid sequences of these Za domains show
relatively little sequence identity (between 19% and 39%);
in contrast to the proteins as a whole, the residues
that make contact with DNA are highly conserved
(Figure 1) (14–16). Many, including the asparagine and
tyrosine in the recognition helix a-3, and the ﬁrst proline
and tryptophan in the wing b-3 are invariant in proteins
that bind Z-DNA, while the rest show mostly conservative
changes. An exception is the Thr-191 of hZaADAR1;
this residue makes contact with the DNA in the
hZaADAR1 co-crystal structure, but is not well conserved
in other Zas. Even between poxvirus proteins there is no
observable conservation of residues that do not contact
DNA. In order to determine the eﬀect on DNA binding
of sequence variability in the Za domains from E3L
proteins, the activity of these domains was examined,
with a focus on the eﬀect of the residues preceding the
invariant proline. We will henceforth refer to the two
residues preceding the conserved proline as ‘P-2’ and ‘P-1’
(Figure 1).
Characterization of theinteraction between theZaE3L
poxviruses and Z-DNA by SPR
The viral Za domains shown in Figure 1 were puriﬁed
from E. coli. Z-DNA-binding activities of these viral
Zas were determined using SPR. The equilibrium-binding
constant (KD) values were calculated from association
(kon) and dissociation (koﬀ) rate constants determined
by ﬁtting real-time kinetic data. As shown in Table 1,
the binding constants ranging from 60 to 177nM. This is
comparable to the binding aﬃnity of hZaADAR1,5 7 n M
(Table 1). Data from a typical SPR experiment is shown
in supporting information (Figure S1).
Conversion ofB toZ-DNA bypoxviral Za proteins
DNA with the sequence d(CG)n can be stabilized into
Z-form by the binding of hZaADAR1; the B–Z transition
has been observed by CD (5,6). Za domains from other
proteins have been characterized by CD for their ability
to induce the B–Z transition (15,16,23,24), and variability
between proteins with comparable binding constants
has been seen. For example, the two Za family domains
from human ZBP1 produce a slower B to Z transition
than hZaADAR1 (23).
As shown in Figure 2, all the tested Za proteins were
able to alter the equilibrium between B- and Z-DNA
in these experiments, with the exception of vZaE3L.
Although, vZaE3L is not able to change the B–Z
equilibrium under these conditions, its binding to
Table 1. Z-DNA-binding aﬃnities of viral Zas
Protein kon (1/Ms) koﬀ (1/s) KD (nM)
hZaADAR1 9.6 10
4 5.47 10
 3 57
yabZaE3L 1.27 10
5 7.56 10
 3 60
vZaE3L 1.14 10
4 1.36 10
 3 120
spZaE3L 4.21 10
4 7.44 10
 3 177
lsZaE3L 4.84 10
4 7.98 10
 3 165
orfZaE3L 7.18 10
4 12.4 10
 3 173
The binding aﬃnities (KD)o fZ as for Z-DNA were calculated from
association (kon) and dissociation (koﬀ) rate constants determined using
surface plasmon resonance (Biacore).
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and in vivo (8). On the other hand, the rate of B to Z
conversion by yabZaE3L and the equilibrium state are the
same as that of hZaADAR1 (16). The other Za proteins
yield slower and less complete B–Z transitions than
yabZaE3L, but faster and more complete than vZaE3L.
One way to quantify the results obtained by CD is to
normalize the data with respect to hZaADAR1.h Z aADAR1
is the best characterized Za family protein and binds
extremely tightly and speciﬁcally. Two comparisons
can be made: (i) the extent of Z-DNA stabilization and
(ii) the time required to reach equilibrium. By both of
these criteria, the order of B to Z conversion was
hZaADAR1 yabZaE3L>lsZaE3L>orfZaE3L spZaE3L.
Proteins that produce a faster, more complete conver-
sion from the B to the Z-form tend to have a faster
kon as determined by SPR, however the correlation is
not consistent. orfZaE3L has a kon of 7.2 10
4, higher than
spZaE3Lor lsZaE3L, but results in slower and less complete
stabilization of Z-DNA than lsZaE3L. It should be noted
that the SPR experiments measure the binding of
Za protein to preformed Z-DNA, while the CD experi-
ments observe a conformational change in dsDNA
induced by the protein. Factors including the oﬀ rate,
the speciﬁc geometry and contacts between the protein
and the Z-DNA are likely to aﬀect the conversion of
B-DNA to Z-DNA in a diﬀerent way than the binding to
pre-stabilized Z-DNA.
Gain ofBto Z-DNA conversion activity inavZaE3L mutant
The Za domain from vaccinia virus E3L appears inert in
the CD experiments shown above. However, tight and
speciﬁc binding to Z-DNA has been shown previously (8),
and SPR shows that it binds preformed Z-DNA more
tightly than spZaE3L, lsZaE3L or orfZaE3L. This apparent
contradiction correlates with a low on rate, an order
of magnitude less that that of yabZaE3L (Table 1).
The solution structure of vZaE3L shows a considerable
diﬀerence between the position and sequence of this wing
and that of yabZaE3L, which binds tightly and speciﬁcally
in all assays [Figure 3 and (16,17)]. In order to assess the
importance of residues in the b-wing (b-2, b-3 and the
loop region in-between, Figure 1), Asp-60 (P-2) and Ile-61
(P-1) in vZaE3L were both changed to threonines.
For comparison, yabZaE3L was also mutated to more
closely resemble vZaE3L in sequence: Ser-64 (P-2) and
Figure 2. The conversion of poly (dG–dC) from the B to Z
conformation by Za.( A) Conversion of B-DNA to Z-DNA by Za
proteins measured by CD in the range of 230–320nm. The spectra of
the B-form (gray) and Z-form (black, stabilized by hZaADAR1) of poly
(dG–dC) are shown for comparison. The spectra of yabZaE3L (red),
lsZaE3L (green), orfZaE3L (blue), spZaE3L (pink) and vZaE3L (black) are
also shown as circles. Equilibrium states are shown. The drop in ellipticity
below 240nm is due to the protein. (B) Kinetics of the conformation
change from B-DNA to Z-DNA in the presence of Za proteins.
The change in ellipticity at 255nm was monitored as a function of time.
hZaADAR1(thickblack),yabZaE3L(red),lsZaE3L(green),orfZaE3L(blue),
spZaE3L (pink) and vZaE3L (thin black) are shown.
Figure 3. The interaction between Z-DNA and the b-wing region
of yabZaE3L (red) and vZaE3L (blue) as determined structurally.
The structure of vZaE3L determined by NMR (17) is superimposed
on the structure of yabZaE3L in a complex with Z-DNA (16) using a3
as the superposition template. The b-wing is positioned parallel to the
DNA backbone in vZaE3L, leaving the P-1 and P-2 residues some
distance from the DNA. In contrast, these residues are very close to the
DNA backbone in yabZaE3L. Although contacts between the P-2
residue and DNA have not been seen in structural studies of these
complexes, it is possible that an interaction forms between this residue
and intermediates between B-DNA and Z-DNA.
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Changing the residues at P-2 and P-1 in the b-wing can
signiﬁcantly aﬀect the ability of a Za protein to convert
DNA from the B to the Z conformation, as shown in
Figure 4. The mutation yabZaE3LSN6465TT has no
eﬀect—rate and equilibrium of the B-DNA to Z-DNA
conversion are unchanged. In contrast, yabZaE3LSN64
65DI produces a decreased rate and lower equilibrium.
Examination of the structure of the b-wing (Figure 3)
suggests an explanation for this eﬀect. The wing
from vZaE3L is positioned parallel to the DNA, aligning
the two prolines nearest to the backbone, while the wing
from yabZaE3L extends toward the backbone, providing
DNA interactions not only with the prolines but also
with the Asn at P-1. It is possible that both P-1 and P-2
amino acid residues can make DNA contacts, possibly
with DNA in an intermediate state between B and Z.
These residues would then play a larger role in the
conversion of DNA from the B to the Z-form than
in binding to pre-stabilized Z-DNA. If this is true,
positively charged and polar residues at positions P-1
and P-2 should eﬀect the B to Z-DNA transition
better non-polar amino acids and much better than
negatively charged amino acids. The yabZaE3L mutants
described above both satisfy this prediction. In the case
of vZaE3L, the negatively charged Asp at P-2 could
decrease binding to DNA, and the neutral Ile at P-1
cannot form hydrogen binds. The mutations D60T and
I61T, vZaE3LDI6061TT, remove one negative charge and
oﬀer the possibility of hydrogen bonds at both sites.
Effectof changes in P-1and P-2 in other viralZas
To further test the hypothesis, mutations were made in
other Za domains from E3L proteins. When both P-1 and
P-2 were changed to threonine in orfZaE3L, a pronounced
increase in the proportion of Z-DNA at equilibrium and
the rate of conversion were seen (Figure 5 and Table 2).
In order to determine whether changes at both P-1 and P-2
were required for this eﬀect, the single mutations
orfZaE3LGN5455TN and orfZaE3LGN5455GT were
tested. As shown in Figure 5, the orfZaE3LGN5455TN
mutation was suﬃcient to produce the increased binding.
Changing Gly at P-2 to another amino acid acts to stiﬀen
the b-turn; this will increase Z-DNA binding, except in
the case of a negatively charged amino acid, which
will destabilize binding due to electrostatic eﬀects, as
demonstrated by orfZaE3LGN5455DI (Table 2).
Similar experiments with spZaE3L verify that for
these proteins, a change to threonine at position P-2 is
suﬃcient to increase the stabilization of Z-DNA (Table 2).
This result is unexpected because the residue at position
P-1 contacts the Z-DNA in hZaADAR1 and yabZaE3L;
therefore an eﬀect of optimizing the residue at that
position is more expected. The notable eﬀect of sequence
at P-2 supports the idea that this residue plays a role in
either making a binding intermediate between protein
and DNA, or, attractively, in shifting the equilibrium
between B-DNA and Z-DNA by stabilizing an inter-
mediate. This later possibility explains the discrepancy
between KD values and CD data.
When positions P-2 and P-1 are changed to aspartic
acid and isoleucine, respectively, in orfZaE3L or spZaE3L,
the eﬀect is the same as that seen in yabZaE3LSN6465DI
(Table 2). The mutant proteins bind Z-DNA less well.
This supports the hypothesis that these residues are not
optimized for DNA binding in vZaE3L.
Although a single threonine at position P-2 increases
the B- to Z-DNA conversion activity of orfZaE3L and
spZaE3L as much as the double mutant, this is not true for
vZaE3L (Table 2). In the case of the vaccinia protein,
Figure 4. Eﬀect of changes in the b-wing of yabZaE3L and vZaE3L.
Kinetics of the change in DNA conformation in the presence of
yabZaE3L (red), vZaE3L (black), yabZaE3LSN6465TT (green),
yabZaE3LSN6465DI (blue) and vZaE3LDI6061TT (gray) are shown.
vZaE3LDI6061TT, containing two threonines at P-1 and P-2, gains
signiﬁcant activity. The mutation yabZaE3LSN6566TT does not aﬀect
activity, but yabZaE3LSN6566DI has reduced activity.
Figure 5. Eﬀects of hydrogen bond forming mutations at P-1 and P-2
in the variable regions of orfZaE3L on B to Z-DNA conversion activity.
Kinetic measurements of DNA conformation change from B-DNA to
Z-DNA in orfZaE3L (green) and its variable region mutants—
orfZaE3LGN5455TN (blue), orfZaE3LGN5455TT (blue) and
orfZaE3LGN5455GT (black)—were carried out to investigate eﬀects
of hydrogen bond forming potentials by amino acid residues in the
variable region (P-1 and P-2). When both amino acid residues at P-1
and P-2 have abilities to form hydrogen bond(s), these mutants show
better B to Z-DNA conversion activities than wild types or other
mutants that have Gly (orfZaE3L) or Ala (spZaE3L) at P-2 position,
respectively. This may indicate that the amino acid residue at P-2 could
contribute to B to Z-DNA conversion possibly by hydrogen-bond
interaction(s) with Z-DNA backbones as is found in P-1.
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any activity in the CD assay. This suggests that the
position of the b-wing of vZaE3L remains diﬀerent for that
of yabZaE3L, even in the presence of a single mutation.
It is likely that other residues also play a role in
positioning the wing.
Effect ofacharged aminoacid inposition P-2
It has been hypothesized that the presence of a positively
charged amino acid at position P-2 could increase
the ability of a Za protein to alter the equilibrium between
B-DNA and Z-DNA. This was tested by making mutants
of vZaE3L, orfZaE3L and spZaE3L, in each of which P-2
and P-1 were changed to lysine and threonine, respec-
tively. As predicted, the presence of the positively charged
lysine improved the ability of the protein to stabilize
Z-DNA (Table 2). In each case, the KT mutant performed
better than the TT mutant. This supports the idea
that residues P-1 and P-2 are close to or make contact
with the DNA backbone, as part of a binding intermediate
and/or in the ﬁnal Z-DNA–protein complex. Binding to
and stabilization of Z-DNA by a Za protein can be
optimized if residue P-2 is positively charged and residue
P-1 is able to form a hydrogen bind to a backbone
phosphate.
Biological implications ofmodulation ofZ-DNA
binding by viralZas
Although residues that are required for binding to Z-DNA
are well conserved in Za domains from viral E3L
gene products, we have shown that there are residues
that modulate DNA binding, which are conserved poorly
or not at all. On one hand, yabZaE3L binds to Z-DNA
extremely tightly, and is fully capable of stabilizing
appropriate sequences in the Z conformation. On the
other, vZaE3L cannot stabilize Z-DNA in the absence
of other factors such as cobalt hexamine or negative
supercoiling. Nevertheless, it is in vaccinia virus that it
has been shown that the ability of E3L to bind Z-DNA is
essential for viral pathogenicity (19).
In vaccinia infections, it is essential for ZaE3L to bind
Z-DNA; mutations that decrease Z-DNA binding of
vZaE3L decrease the pathogenicity of the virus (19).
However, it is possible that viral E3L proteins do not
have to stabilize Z-DNA in the absence of other
factors, but rather bind to Z-DNA stabilized by factors
such as negative supercoiling. Perhaps certain viral Zas,
e.g. vZaE3L, do not need to stabilize Z-DNA on their own.
Substitution of a stronger Za domain such as hZaADAR1
or mZaZBP1 for vZaE3L in a chimeric E3L maintains
pathogenicity but does not increase it (19).
Our study demonstrates that viral Zas from diﬀerent
poxviruses have diﬀerent ability for Z-DNA stabilization.
The variability in the sequence of the b-wing and
the modulation in Z-DNA-binding activity may reﬂect
the lifecycle of the virus. In each of viruses, diﬀerent
degrees of modulation of Z-DNA-binding activity may be
essential. Too weak binding will inactivate the Za, but too
much binding may result in binding to inappropriate
targets or the activation of genes that will hamper
viral activity.
The biological action of the diﬀerent viral Za domains
can only be the object of speculation at present. When
transfected into a cultured cell, Za can prevent apoptosis,
stopping one of the most powerful host defenses against
viral infection. Expression of Za also regulates the
expression of many genes (20), and may act thus in viral
pathogenesis. Finally, viral Zas may compete with cellular
Zas or other, as yet undiscovered, Z-DNA-binding
proteins, much as the C-terminal dsRNA-binding
domain acts by competing for substrate with PKR.
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Table 2. Eﬀects on the degrees of B to Z-DNA conversion and the time
to saturation for mutations in the b-wing region
Protein % conversion Time to
saturation (s)
Mutation (s)
in the b-wing
hZaADAR1 100 1000 Wild type
yabZaE3L 100 1000 Wild type
SN6465TT 100 1000 P-1/P-2
SN6465DI 80 1600 P-1/P-2
vZaE3L 0 1
a Wild type
DI6061TT 35 >3600
b P-1/P-2
DI606DT 0 1
a P-2
DI6061TI 0 1
a P-1
DI6061KT 40 >3600
b P-1/P-2
orfZaE3L 65 2000 Wild type
GN5455TT 80 2000 P-1/P-2
GN5455GT 65 2000 P-2
GN5455TN 80 2000 P-1
GN5455KT 80 2000 P-1/P-2
GN5455DI 50 >3600
b P-1/P-2
spZaE3L 65 2000 Wild type
AC6162TT 80 2000 P-1/P-2
AC6162AT 65 2000 P-2
AC6162TC 80 2000 P-1
AC6162KT 80 2000 P-1/P-2
AC6162DI 50 >3600
b P-1/P-2
lsZaE3L 90 1400 Wild type
Results are normalized to hZaADAR1, which is set to 100% conversion.
Time to saturation is measured from t=0 to the point where the curve
becomes horizontal.
aNo activity.
bDoes not reach saturation within 1h.
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